Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments

Ashokkumar Jain; Ruichao Xu; Raman Venkataramanan; Umar Farooq; Fauzia Butt; Nasrollah Ghahramani; Zakiyah Kadry

doi:10.1097/TP.0000000000003840

Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments

Ashokkumar Jain, Ruichao Xu, Raman Venkataramanan, Umar Farooq, Fauzia Butt, Nasrollah Ghahramani, Zakiyah Kadry

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E152-E153
Journal	Transplantation
Volume	105
Issue number	10
DOIs	https://doi.org/10.1097/TP.0000000000003840
State	Published - Oct 1 2021

All Science Journal Classification (ASJC) codes

Transplantation

Access to Document

10.1097/TP.0000000000003840

Cite this

@article{e07ce86281174f55a63c27b4a672f2a3,

title = "Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments",

author = "Ashokkumar Jain and Ruichao Xu and Raman Venkataramanan and Umar Farooq and Fauzia Butt and Nasrollah Ghahramani and Zakiyah Kadry",

note = "Funding Information: Bristol Myers Squibb—PPK supported the grant from Bristol Myer Squibb to analyze the serum sample for belatacept concentration through PPD, exclusive proprietary rights by BMS. ",

year = "2021",

month = oct,

day = "1",

doi = "10.1097/TP.0000000000003840",

language = "English (US)",

volume = "105",

pages = "E152--E153",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Plasmapheresis Decreases Belatacept Exposure

T2 - Requires Consideration for Dose and Frequency Adjustments

AU - Jain, Ashokkumar

AU - Xu, Ruichao

AU - Venkataramanan, Raman

AU - Farooq, Umar

AU - Butt, Fauzia

AU - Ghahramani, Nasrollah

AU - Kadry, Zakiyah

N1 - Funding Information: Bristol Myers Squibb—PPK supported the grant from Bristol Myer Squibb to analyze the serum sample for belatacept concentration through PPD, exclusive proprietary rights by BMS.

PY - 2021/10/1

Y1 - 2021/10/1

UR - http://www.scopus.com/inward/record.url?scp=85116584953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116584953&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000003840

DO - 10.1097/TP.0000000000003840

M3 - Letter

C2 - 34591818

AN - SCOPUS:85116584953

SN - 0041-1337

VL - 105

SP - E152-E153

JO - Transplantation

JF - Transplantation

IS - 10

ER -

Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this